BRIEF-UniQure on Track To Begin Pivotal Study Of AMT-061 In Hemophilia B In Q3 By: Reuters: Company News March 14, 2018 at 07:08 AM EDT * UNIQURE ANNOUNCES 2017 FINANCIAL RESULTS AND RECENT COMPANY PROGRESS Read More >> Related Stocks: Uniqure Ord Shs